Skip to main content
. 2022 Feb 15;10:814714. doi: 10.3389/fcell.2022.814714

FIGURE 3.

FIGURE 3

Potential therapeutic targets in tumor hybrid cells. TLR4, toll-like receptor 4; MMP9, matrix metalloproteinase 9; Wnt/β-catenin, signaling pathway; Nanog, transcription factor.